Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Structure and biogenesis of small nucleolar RNAs acting as guides for ribosomal RNA modification.
Filipowicz W, Pelczar P, Pogacic V, Dragon F. Filipowicz W, et al. Among authors: pogacic v. Acta Biochim Pol. 1999;46(2):377-89. Acta Biochim Pol. 1999. PMID: 10547039 Review.
Biogenesis of small nucleolar ribonucleoproteins.
Filipowicz W, Pogacić V. Filipowicz W, et al. Among authors: pogacic v. Curr Opin Cell Biol. 2002 Jun;14(3):319-27. doi: 10.1016/s0955-0674(02)00334-4. Curr Opin Cell Biol. 2002. PMID: 12067654 Review.
Human H/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and NOP10.
Pogacić V, Dragon F, Filipowicz W. Pogacić V, et al. Mol Cell Biol. 2000 Dec;20(23):9028-40. doi: 10.1128/mcb.20.23.9028-9040.2000. Mol Cell Biol. 2000. PMID: 11074001 Free PMC article.
In vitro assembly of human H/ACA small nucleolar RNPs reveals unique features of U17 and telomerase RNAs.
Dragon F, Pogacić V, Filipowicz W. Dragon F, et al. Among authors: pogacic v. Mol Cell Biol. 2000 May;20(9):3037-48. doi: 10.1128/mcb.20.9.3037-3048.2000. Mol Cell Biol. 2000. PMID: 10757788 Free PMC article.
Conserved composition of mammalian box H/ACA and box C/D small nucleolar ribonucleoprotein particles and their interaction with the common factor Nopp140.
Yang Y, Isaac C, Wang C, Dragon F, Pogacic V, Meier UT. Yang Y, et al. Among authors: pogacic v. Mol Biol Cell. 2000 Feb;11(2):567-77. doi: 10.1091/mbc.11.2.567. Mol Biol Cell. 2000. PMID: 10679015 Free PMC article.
Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity.
Pogacic V, Bullock AN, Fedorov O, Filippakopoulos P, Gasser C, Biondi A, Meyer-Monard S, Knapp S, Schwaller J. Pogacic V, et al. Cancer Res. 2007 Jul 15;67(14):6916-24. doi: 10.1158/0008-5472.CAN-07-0320. Cancer Res. 2007. PMID: 17638903 Free article.
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Fedorov O, Marsden B, Pogacic V, Rellos P, Müller S, Bullock AN, Schwaller J, Sundström M, Knapp S. Fedorov O, et al. Among authors: pogacic v. Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20523-8. doi: 10.1073/pnas.0708800104. Epub 2007 Dec 11. Proc Natl Acad Sci U S A. 2007. PMID: 18077363 Free PMC article.
Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL.
Adam M, Pogacic V, Bendit M, Chappuis R, Nawijn MC, Duyster J, Fox CJ, Thompson CB, Cools J, Schwaller J. Adam M, et al. Among authors: pogacic v. Cancer Res. 2006 Apr 1;66(7):3828-35. doi: 10.1158/0008-5472.CAN-05-2309. Cancer Res. 2006. PMID: 16585210 Free article.
List of drugs in development for neurodegenerative diseases. Update June 2007.
Pogacić V, Herrling P. Pogacić V, et al. Neurodegener Dis. 2007;4(6):443-86. doi: 10.1159/000107705. Neurodegener Dis. 2007. PMID: 17934328 Free article. No abstract available.
Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migration.
Grundler R, Brault L, Gasser C, Bullock AN, Dechow T, Woetzel S, Pogacic V, Villa A, Ehret S, Berridge G, Spoo A, Dierks C, Biondi A, Knapp S, Duyster J, Schwaller J. Grundler R, et al. Among authors: pogacic v. J Exp Med. 2009 Aug 31;206(9):1957-70. doi: 10.1084/jem.20082074. Epub 2009 Aug 17. J Exp Med. 2009. PMID: 19687226 Free PMC article.
11 results
Jump to page